Isabelle Rocher

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 833 citations

Drug Safety, Compromise Treatment, Pulmonary Tuberculosis +15

Factors associated with compliance in treatment of tuberculosis

Richard Menzies, Isabelle Rocher, Bilkis Vissandjée · Tubercle and Lung Disease · 1993 · 89 citations

Pulmonary Tuberculosis, Preventive Medicine, Treatment And Prevention +9

The impact of smoking on adherence to treatment for latent tuberculosis infection

M. Lavigne, Isabelle Rocher, Colin Steensma et al. · BMC Public Health · 2006 · 67 citations · Full text

Healthcare-Associated Bloodstream Infections Secondary to a Urinary Focus The Québec Provincial Surveillance Results

Élise Fortin, Isabelle Rocher, Charles Frenette et al. · Infection Control and Hospital Epidemiology · 2012 · 44 citations

Central Line–Associated Bloodstream Infection in Neonatal Intensive Care Units

Ana C. Blanchard, Élise Fortin, Isabelle Rocher et al. · Infection Control and Hospital Epidemiology · 2013 · 36 citations